The Assembly will consider Document A64/16, the report of the Working Group of Member States on Substandard/Spurious/FalselyLabelled/Falsified/Counterfeit Medical Products, established by decision WHA63(10), which met in Geneva from 28 February to 2 March 2011 (see Annex).